Cyndeo Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Cyndeo Wealth Partners's ABBV Position: Q2 2026 in Review
Cyndeo Wealth Partners increased its AbbVie (ABBV) stake by 0.22% in Q2 2026, buying an estimated $65.6K and bringing the position to 137,211 shares worth $34.5M. The position accounts for 1.63% of the portfolio, ranked #6.
Cyndeo Wealth Partners first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Cyndeo Wealth Partners held 137,211 shares of AbbVie worth $34.5M as of Q2 2026.
- Cyndeo Wealth Partners bought 305 AbbVie shares in Q2 2026, an estimated $65.6K.
- AbbVie made up 1.63% of Cyndeo Wealth Partners's portfolio in Q2 2026, its #6 holding.
- Cyndeo Wealth Partners first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Cyndeo Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.